相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
Shannon Cope et al.
RESPIRATORY RESEARCH (2013)
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
Marc L. Decramer et al.
LANCET RESPIRATORY MEDICINE (2013)
Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease
Jae Seung Lee et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2012)
Tiotropium Bromide Inhalation Powder A Review of its Use in the Management of Chronic Obstructive Pulmonary Disease
Gillian M. Keating
DRUGS (2012)
Limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease
Yaning Wang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2012)
Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
Kai-Michael Beeh et al.
RESPIRATORY RESEARCH (2012)
Efficacy and safety of indacaterol 150 and 300 μg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12-week, placebo-controlled study
Masaharu Kinoshita et al.
RESPIROLOGY (2012)
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison
Donald A. Mahler et al.
THORAX (2012)
β2-adrenoceptor agonists: current and future direction
Mario Cazzola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD A Randomized, Placebo-Controlled Study
Kenneth R. Chapman et al.
CHEST (2011)
Efficacy and Tolerability of Indacaterol 75 μg Once Daily in Patients Aged ≥40 Years With Chronic Obstructive Pulmonary Disease: Results From 2 Double-Blind, Placebo-Controlled 12-Week Studies
Edward M. Kerwin et al.
CLINICAL THERAPEUTICS (2011)
Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD
Kai-Michael Beeh et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2011)
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison
O. Kornmann et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
R. Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Third-generation long-acting β2-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β2-adrenoceptor agonists
John R. Jacobsen
FUTURE MEDICINAL CHEMISTRY (2011)
Safety, tolerability and pharmacokinetics of single escalating doses of indacaterol, a once-daily β2-agonist bronchodilator, in subjects with COPD
S. Pascoe et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
The Risks and Benefits of Indacaterol - The FDA's Review
Badrul A. Chowdhury et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD
Denis E. O'Donnell et al.
RESPIRATORY MEDICINE (2011)
Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: A 12-week study
Stephanie Korn et al.
RESPIRATORY MEDICINE (2011)
Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study
Craig LaForce et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi
Maria G. Matera et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study
Sanjeev Khindri et al.
BMC PULMONARY MEDICINE (2011)
Safety of indacaterol in the treatment of patients with COPD
James F. Donohue et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2011)
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
Didier Renard et al.
RESPIRATORY RESEARCH (2011)
The Short, the Long, and the Ultra-long: Why Duration of Bronchodilator Action Matters in Chronic Obstructive Pulmonary Disease
Kai M. Beeh et al.
ADVANCES IN THERAPY (2010)
Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease Indacaterol Versus Tiotropium
James F. Donohue et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol
Richard Pavkov et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist
Francois Baur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled β2-adrenoceptor agonists
Elizabeth M. Rosethorne et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Indacaterol once-daily is equally effective dosed in the evening or morning in COPD
H. Magnussen et al.
RESPIRATORY MEDICINE (2010)
Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
Peter J. Barnes et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy
M. Weatherall et al.
THORAX (2010)
Efficacy of a new once-daily long-acting inhaled β2-agonist indacaterol versus twice-daily formoterol in COPD
Ronald Dahl et al.
THORAX (2010)
Efficacy and safety of indacaterol 150 mu g once-daily in COPD: a double-blind, randomised, 12-week study
Gregory Feldman et al.
BMC PULMONARY MEDICINE (2010)
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
Claus Vogelmeier et al.
RESPIRATORY RESEARCH (2010)
24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol
Olivier Bauwens et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol
Craig LaForce et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties?
Dario Lombardi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials
M. R. Sears et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Risk of mortality associated with formoterol: a systematic review and meta-analysis
M. Wijesinghe et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Enantiomer-Specific Effects of Albuterol on Airway Inflammation in Healthy and Asthmatic Cats
Carol R. Reinero et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2009)
Pharmacologic Treatments for Chronic Obstructive Pulmonary Disease: A Mixed-Treatment Comparison Meta-analysis
William L. Baker et al.
PHARMACOTHERAPY (2009)
Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review
Gustavo J. Rodrigo et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: A multicenter, randomized study
Claudia Cote et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Bronchodilator effects of indacaterol and formoterol in patients with COPD
J. Beier et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Bronchodilator efficacy of indacaterol, a novel once-daily β2-agonist, in patients with persistent asthma
David S. Pearlman et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Novel long-acting bronchodilators for COPD and asthma
M. Cazzola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Inspiratory flow rates at different levels of resistance in elderly COPD patients
W. Janssens et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Outcomes for COPD pharmacological trials:: from lung function to biomarkers
M. Cazzola et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Efficacy and Safety of Indacaterol, a New 24-hour 2-Agonist, in Patients with Asthma: A Dose-Ranging Study
Frank Kanniess et al.
JOURNAL OF ASTHMA (2008)
Cholesterol-dependent Separation of the β2-Adrenergic Receptor from Its Partners Determines Signaling Efficacy INSIGHT INTO NANOSCALE ORGANIZATION OF SIGNAL TRANSDUCTION
Stephanie M. Pontier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison
Stephen Rennard et al.
RESPIRATORY MEDICINE (2008)
Pharmacological characterization of indacaterol, a novel once daily inhaled beta(2) adrenoceptor agonist, on small airways in human and rat precision-cut lung slices
Richard G. Sturton et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study
C. LaForce et al.
ALLERGY (2008)
Tolerability of indacaterol, a novel once-daily β2-agonist, in patients with asthma:: a randomized, placebo-controlled, 28-day safety study
William H. Yang et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Effects of formoterol on exercise tolerance in severely disabled patients with COPD
J. Alberto Neder et al.
RESPIRATORY MEDICINE (2007)
Safety and tolerability of indacaterol in asthma: A randomized, placebo-controlled 28-day study
Alexander G. Chuchalin et al.
RESPIRATORY MEDICINE (2007)
Adherence to treatment by patients with asthma or COPD: Comparison between inhaled drugs and transdermal patch
Gen Tamura et al.
RESPIRATORY MEDICINE (2007)
Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma
K. M. Beeh et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Effect of inclacaterol, a novel long-acting β2-agonist, on isolated human bronchi
E. Naline et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD:: A 28-day randomised, placebo controlled clinical trial
Jutta Beier et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
In vitro and in vivo pharmacological characterization of 5-[(R)2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a novel inhaled β2 adrenoceptor agonist with a 24-h duration of action
C Battram et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The salmeterol multicenter asthma research trial - A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol
HS Nelson et al.
CHEST (2006)
In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler
W Tarsin et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2004)
Assessment of handling of inhaler devices in real life: An observational study in 3811 patients in primary care
M Molimard et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2003)
β-adrenoceptor agonists and asthma -: 100 years of development
B Waldeck
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
R Dahl et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Effective delivery of particles with the HandiHaler® dry powder inhalation system over a range of chronic obstructive pulmonary disease severity
S Chodosh et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2001)
分享论文
